Grant: CIHR Fellowship
Ottawa Hospital Research Institute
$135,000.00
Methodological issues in the design and analysis of cluster randomized controlled trials in hemodialysis
EF 2020-21
Résumé
The cluster-randomized trial is an important design for evaluating health service interventions in the outpatient hemodialysis (HD) setting. Cluster-randomized trials randomize intact groups of people (such as patients being treated in HD centres) rather than individuals. In the HD setting, a cluster-randomized trial design is a logical choice when the intervention is delivered at the centre-level, where nurses in each centre are trained to follow similar protocols for all patients. Also, when study outcomes are available from routinely collected sources (called "registries"), cluster randomization gives researchers an efficient way for following patients during the trial. This design and registries can reduce trial costs, time, and patient loss to follow-up. Moreover, this design can help avoid treatment contamination when patients in the same HD centre are on the same intervention compared to a setting where multiple interventions are in place at one centre (e.g., evaluating different advertising strategies to encourage smoking cessation). However, there are some challenges to conducting cluster-randomized trials.
This fellowship addresses three methodological gaps in the existing literature to design, conduct, and analyze CRTs unique to the HD setting. The three proposed projects are embedded within a CIHR-funded platform with the primary objective of conducting large-scale, pragmatic, registry-based CRTs in the HD setting. Our results will directly inform the design and analysis of Canadian HD trials within our funded SPOR Innovative Clinical Trial Multi-Year Grant.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
440790
Name
Al-Jaishi Ahmed
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Methodological issues in the design and analysis of cluster randomized controlled trials in hemodialysis
Programtype2
Fellowship Programs
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Administrative Data; Cluster Randomized Trials; End-Stage Kidney Disease; Epidemiology; Hemodialysis; Kidney
Abstract
The cluster-randomized trial is an important design for evaluating health service interventions in the outpatient hemodialysis (HD) setting. Cluster-randomized trials randomize intact groups of people (such as patients being treated in HD centres) rather than individuals. In the HD setting, a cluster-randomized trial design is a logical choice when the intervention is delivered at the centre-level, where nurses in each centre are trained to follow similar protocols for all patients. Also, when study outcomes are available from routinely collected sources (called "registries"), cluster randomization gives researchers an efficient way for following patients during the trial. This design and registries can reduce trial costs, time, and patient loss to follow-up. Moreover, this design can help avoid treatment contamination when patients in the same HD centre are on the same intervention compared to a setting where multiple interventions are in place at one centre (e.g., evaluating different advertising strategies to encourage smoking cessation). However, there are some challenges to conducting cluster-randomized trials.
This fellowship addresses three methodological gaps in the existing literature to design, conduct, and analyze CRTs unique to the HD setting. The three proposed projects are embedded within a CIHR-funded platform with the primary objective of conducting large-scale, pragmatic, registry-based CRTs in the HD setting. Our results will directly inform the design and analysis of Canadian HD trials within our funded SPOR Innovative Clinical Trial Multi-Year Grant.
Competitiondate
202012
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Al-Jaishi, Ahmed
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~